Quick Answer
MADRIGAL PHARMACEUTICALS, INC. reported Common Stock Shares Outstanding of 22.84 million shares for the year ending 2025.
- MADRIGAL PHARMACEUTICALS, INC. showed an increase of +3.8% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from MADRIGAL PHARMACEUTICALS, INC.'s annual report (Form 10-K), filed with the SEC on February 19, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 16 years of available data (2010 to 2025), MADRIGAL PHARMACEUTICALS, INC.'s Common Stock Shares Outstanding has declined by 45.7%.
- Historical annual values: Fiscal year 2025: 22.84 million shares | Fiscal year 2024: 22.00 million shares | Fiscal year 2023: 19.88 million shares | Fiscal year 2022: 18.10 million shares | Fiscal year 2021: 17.10 million shares | Fiscal year 2020: 15.51 million shares | Fiscal year 2019: 15.43 million shares | Fiscal year 2018: 15.41 million shares | Fiscal year 2017: 14.23 million shares | Fiscal year 2016: 11.95 million shares | Fiscal year 2015: 176,158 shares | Fiscal year 2014: 109.12 million shares | Fiscal year 2013: 85.23 million shares | Fiscal year 2012: 68.93 million shares | Fiscal year 2011: 49.54 million shares | Fiscal year 2010: 42.09 million shares.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: